SaveHealth explores the potential prescription cost savings that can be achieved by leveraging cash prices and discount cards, providing insights based on real-world drug pricing data.

Medicare will seek to negotiate lower list prices for the blockbuster diabetes and weight loss drugs Ozempic and Wegovy and ...

The companies raised prices a median 4%, though some drugs will cost thousands of dollars more.

The hugely popular medications Ozempic and Wegovy​, used for diabetes and weight loss, will be included in the next round of ...

As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...

Under the new deals, list prices were reduced by hundreds — in some cases, thousands — of dollars for 30-day supplies of popular drugs used by millions of people on Medicare. They included ...

Medicare will seek to negotiate lower list prices for the blockbuster diabetes and weight loss drugs Ozempic and Wegovy and 14 other medications, a cost-saving move that would take effect in 2027.